EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;34:289-294. doi:10.1016/j.ejcts.2008.05.011
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Martin Strüber
Pierre-Yves Litzler
Francesco Musumeci
Christian Schlensak
Ivar Friedrich
Ronny Gustafsson
Frank Oertel
Pascal Leprince
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Strüber, M.
Right arrow Articles by Leprince, P.
PubMed
Right arrow Articles by Strüber, M.
Right arrow Articles by Leprince, P.
Related Collections
Right arrow Mechanical Circulatory Assistance

HeartMate II left ventricular assist device; early European experience

Martin Strübera,*, Kare Sanderb, Jaap Lahporc, Henrik Ahnd, Pierre-Yves Litzlere, Stavros G. Drakosf, Francesco Musumecig, Christian Schlensakh, Ivar Friedrichi, Ronny Gustafssonj, Frank Oertelk, Pascal Leprincel

a Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
b Department of Cardiothoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
c Department of Cardiothoracic Surgery, Heart Lung Center, University Medical Center Utrecht, Utrecht, Netherlands
d Departments of Cardiovascular Surgery and Anesthesia, University Hospital Linkoping, Linkoping, Sweden
e Department of Thoracic and Cardiac Surgery, Rouen University, Rouen, France
f 3rd Cardiology Department, University Of Athens, Athens, Greece
g Azienda Ospedaliera San Camillo, Rome, Italy
h Department of Cardiovascular Surgery, University Hospital Freiburg, Freiburg, Germany
i University Clinic and Polyclinic for Cardiac und Thoracic Surgery, University Hospital Halle, Halle, Germany
j Heart and Lung Division, Section of Cardiothoracic Surgery, University Hospital Lund, Lund, Sweden
k Department of Cardiac and Thoracic Surgery, Heart Centre Augsburg-Schwaben, Augsburg, Germany
l Thoracic and Cardiovascular Surgery, GH Pitié-Salpêtrière, Paris, France

Received 20 November 2007; received in revised form 9 May 2008; accepted 9 May 2008.

* Corresponding author. Address: Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Tel.: +49 511 532 4179; fax: +49 511 532 8452. (Email: strueber.martin{at}mh-hannover.de).

Objective: The novel axial flow left ventricular assist device HeartMate II was introduced into clinical practice in Europe as part of the pilot study and after CE approval in November 2005. In order to get an overview of the use and performance of the device in Europe a group of investigators was founded to compare the initial results. Methods: In a retrospective analysis of the first 101 consecutive cases in Europe, data were collected with regard to postoperative outcome and severe adverse events and anticoagulation protocols. Results were stratified by intention to treat as a bridge to transplant or as chronic support therapy in heart failure (destination therapy). Results: In 70% of patients, the HeartMate II was intended as a bridge to transplant therapy, in 30%, it was used as a destination therapy device. The perioperative mortality post implant was 20% in the bridge to transplant patients and 7% in the destination therapy arm. However, after 1 year a comparable survival was observed in both groups (69% destination therapy, 63% bridge to transplant). Main causes of death were multiple organ failure (n = 12) and cerebrovascular accidents (n = 5). All, but one cerebrovascular accident occurred in the first 9 days after surgery. Only one other death was reported thereafter and there was no mechanical failure of the device. Conclusions: Even in the early experience the HeartMate II was used as a chronic support device in a substantial number of patients in Europe. Although the total experience is still limited, the incidence of cerebrovascular accidents is very low and the survival beyond the perioperative period is excellent.

Key Words: LVAD • HeartMate II • Adverse events




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Strueber
Editorial comment: Indication for mechanical circulatory support in high urgent heart transplant candidates
Eur. J. Cardiothorac. Surg., December 1, 2008; 34(6): 1134 - 1135.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.